BiotechTube
Home/Gliknik/Raymond Schinazi, Ph.D., D.Sc.
RS

Raymond Schinazi, Ph.D., D.Sc.

Board Member

Gliknik

Therapeutic Areas

Autoimmune DiseasesOncology

Gliknik Pipeline

DrugIndicationPhase
GL-2045Autoimmune diseases (e.g., Immune Thrombocytopenia)Phase 2
GL-0719Autoimmune diseases (e.g., Cold Agglutinin Disease)Phase 2

Leadership Team at Gliknik

DB
David Block
Co-Founder & CEO
PF
Paul Friedman, M.D.
Director
View full Gliknik profile